Lord, Abbett & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-72,154
Closed -$8.9M 639
2020
Q2
$8.9M Buy
72,154
+9,763
+16% +$1.2M 0.03% 499
2020
Q1
$5.27M Sell
62,391
-23,028
-27% -$1.95M 0.02% 530
2019
Q4
$7.22M Sell
85,419
-36
-0% -$3.04K 0.02% 569
2019
Q3
$5.76M Buy
85,455
+7
+0% +$472 0.02% 620
2019
Q2
$7.32M Sell
85,448
-23,307
-21% -$2M 0.02% 613
2019
Q1
$9.66M Buy
108,755
+2,706
+3% +$240K 0.03% 566
2018
Q4
$9.03M Sell
106,049
-5,599
-5% -$477K 0.03% 551
2018
Q3
$10.8M Buy
111,648
+1,272
+1% +$123K 0.03% 611
2018
Q2
$10.4M Buy
110,376
+47,060
+74% +$4.43M 0.03% 614
2018
Q1
$5.13M Buy
+63,316
New +$5.13M 0.02% 721
2017
Q1
Sell
-64,558
Closed -$5.35M 862
2016
Q4
$5.35M Sell
64,558
-197,845
-75% -$16.4M 0.02% 727
2016
Q3
$24.3M Buy
262,403
+193,749
+282% +$17.9M 0.07% 396
2016
Q2
$5.34M Buy
68,654
+2,486
+4% +$193K 0.02% 697
2016
Q1
$5.46M Sell
66,168
-69,923
-51% -$5.77M 0.02% 688
2015
Q4
$14.3M Sell
136,091
-70,923
-34% -$7.43M 0.04% 516
2015
Q3
$21.8M Sell
207,014
-177,622
-46% -$18.7M 0.07% 397
2015
Q2
$52.6M Buy
384,636
+9,911
+3% +$1.36M 0.14% 229
2015
Q1
$46.7M Buy
374,725
+155,714
+71% +$19.4M 0.12% 267
2014
Q4
$19.8M Buy
219,011
+125,526
+134% +$11.3M 0.05% 469
2014
Q3
$6.75M Sell
93,485
-118,515
-56% -$8.55M 0.02% 677
2014
Q2
$13.2M Sell
212,000
-23,000
-10% -$1.43M 0.03% 589
2014
Q1
$16M Sell
235,000
-78,951
-25% -$5.39M 0.04% 529
2013
Q4
$22.1M Buy
313,951
+44,493
+17% +$3.13M 0.05% 511
2013
Q3
$19.5M Buy
269,458
+20,748
+8% +$1.5M 0.04% 527
2013
Q2
$13.9M Buy
+248,710
New +$13.9M 0.03% 570